These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 2869084

  • 1. Activation of complement by pathogenic and nonpathogenic Entamoeba histolytica.
    Reed SL, Curd JG, Gigli I, Gillin FD, Braude AI.
    J Immunol; 1986 Mar 15; 136(6):2265-70. PubMed ID: 2869084
    [Abstract] [Full Text] [Related]

  • 2. Activation of the alternative pathway of complement by Entamoeba histolytica.
    Ortiz-Ortiz L, Capin R, Capin NR, Sepúlveda B, Zamacona G.
    Clin Exp Immunol; 1978 Oct 15; 34(1):10-8. PubMed ID: 219975
    [Abstract] [Full Text] [Related]

  • 3. [Activity of the alternative complement pathway by various axenic strains of Entamoeba histolytica].
    Capin NR, Capin R, Zamacona G, Ortiz-Ortiz L.
    Arch Invest Med (Mex); 1978 Oct 15; 9 Suppl 1():291-6. PubMed ID: 211963
    [Abstract] [Full Text] [Related]

  • 4. Lysis of complement-sensitive Entamoeba histolytica by activated terminal complement components. Initiation of complement activation by an extracellular neutral cysteine proteinase.
    Reed SL, Gigli I.
    J Clin Invest; 1990 Dec 15; 86(6):1815-22. PubMed ID: 2254446
    [Abstract] [Full Text] [Related]

  • 5. Interaction of pathogenic and nonpathogenic Entamoeba histolytica with human complement.
    Reed SL, Gault M, Gillin FD, Gigli I, Braude AI, Curd JG, Sargeaunt PG.
    Arch Invest Med (Mex); 1987 Dec 15; 18(2):141-9. PubMed ID: 2889433
    [No Abstract] [Full Text] [Related]

  • 6. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul 15; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 7. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E, Platt JL, Howell DN, Marsh HC, Frank MM.
    J Immunol; 1999 Sep 15; 163(6):3549-58. PubMed ID: 10477630
    [Abstract] [Full Text] [Related]

  • 8. A mechanism of acquired resistance to complement-mediated lysis by Entamoeba histolytica.
    Gutiérrez-Kobeh L, Cabrera N, Pérez-Montfort R.
    J Parasitol; 1997 Apr 15; 83(2):234-41. PubMed ID: 9105303
    [Abstract] [Full Text] [Related]

  • 9. Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages.
    Mosser DM, Edelson PJ.
    J Immunol; 1984 Mar 15; 132(3):1501-5. PubMed ID: 6363545
    [Abstract] [Full Text] [Related]

  • 10. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
    Tesh VL, Duncan RL, Morrison DC.
    J Immunol; 1986 Aug 15; 137(4):1329-35. PubMed ID: 3525676
    [Abstract] [Full Text] [Related]

  • 11. Activation of the alternative and classical complement pathways by Entamoeba histolytica.
    Calderon J, Schreiber RD.
    Infect Immun; 1985 Nov 15; 50(2):560-5. PubMed ID: 2865212
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of immune precipitation by complement.
    Hong K, Takata Y, Sayama K, Kozono H, Takeda J, Nakano Y, Kinoshita T, Inoue K.
    J Immunol; 1984 Sep 15; 133(3):1464-70. PubMed ID: 6747294
    [Abstract] [Full Text] [Related]

  • 13. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
    Reed SL, Ember JA, Herdman DS, DiScipio RG, Hugli TE, Gigli I.
    J Immunol; 1995 Jul 01; 155(1):266-74. PubMed ID: 7602103
    [Abstract] [Full Text] [Related]

  • 14. Resistance to lysis by human serum of pathogenic Entamoeba histolytica.
    Reed SL, Sargeaunt PG, Braude AI.
    Trans R Soc Trop Med Hyg; 1983 Jul 01; 77(2):248-53. PubMed ID: 6306876
    [Abstract] [Full Text] [Related]

  • 15. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV, Shibanova ED, Zinchenko AA.
    Biokhimiia; 1987 Apr 01; 52(4):660-6. PubMed ID: 3647798
    [Abstract] [Full Text] [Related]

  • 16. Induction of complement resistance in cloned pathogenic Entamoeba histolytica.
    Hamelmann C, Foerster B, Burchard GD, Shetty N, Horstmann RD.
    Parasite Immunol; 1993 Apr 01; 15(4):223-8. PubMed ID: 8506118
    [Abstract] [Full Text] [Related]

  • 17. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K.
    Jpn J Exp Med; 1980 Feb 01; 50(1):13-21. PubMed ID: 6770130
    [Abstract] [Full Text] [Related]

  • 18. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA, Goldman RC, Hammer CH, Leive L, Frank MM.
    J Immunol; 1983 Nov 01; 131(5):2563-9. PubMed ID: 6355296
    [Abstract] [Full Text] [Related]

  • 19. Complement sensitivity of Entamoeba histolytica and various nonpathogenic amoeba species.
    Förster B, Ebert F, Horstmann RD.
    Trop Med Parasitol; 1994 Dec 01; 45(4):355-6. PubMed ID: 7716404
    [Abstract] [Full Text] [Related]

  • 20. Interactions of chrysotile asbestos fibres with the complement system.
    Saint-Remy JM, Cole P.
    Immunology; 1980 Oct 01; 41(2):431-7. PubMed ID: 6904360
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.